ZTEK
BEARISH
$0.48
Live
Zentek Ltd. · NASDAQ
$0.46
52W Range
$1.84
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 24, 2026
Market cap
$51.65M
P/E
N/A
ROE
-56.6%
Profit margin
N/A
Debt/Equity
0.15
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
95%
ZTEK exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While the company shows strong top-line revenue growth of 73.10%, this is completely offset by a catastrophic operating margin of -4155.24% and a Price/Sales ratio of 54.78, suggesting extreme overvaluation. The stock is in a persistent bearish trend with a 58.3% decline over the last year and a lack of any meaningful profitability metrics. Overall, the company appears to be a speculative venture with unsustainable operational costs.
Key Strengths
Strong YoY revenue growth of 73.10%
Low Debt/Equity ratio of 0.15
Healthy Gross Margin of 50.48%
Positive Q/Q revenue growth momentum
Low absolute debt levels relative to equity
Key Risks
Extreme operational inefficiency (Operating Margin -4155.24%)
Severe overvaluation relative to sales (P/S 54.78)
Poor liquidity with a Quick Ratio of 0.67
Consistent history of earnings misses over 16 quarters
Strong bearish technical trend across all timeframes
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
14
Weak
5
40
10
15
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score 1/9, Extreme P/S Ratio, Negative ROE/ROA, Catastrophic Operating Margin
Confidence
90%
Value
5/100
Ref P/S 54.78, P/B 5.72
Positives
No standout positives identified.
Watchpoints
- P/S of 54.78 is unsustainable
- P/B of 5.72 is high for a non-profitable firm
- No Graham Number available due to lack of earnings
Future
40/100
Ref Revenue Growth 73.10%
Positives
- High revenue growth (73%)
Watchpoints
- Inability to convert revenue to profit
- Negative earnings growth trend
Past
10/100
Ref Historical Price Performance and Earnings Track Record
Positives
No standout positives identified.
Watchpoints
- 5Y Change of -73%
- Consistent EPS misses over 16 quarters
Health
15/100
Ref Piotroski F-Score, Quick Ratio
Positives
- Low Debt/Equity
Watchpoints
- Piotroski F-Score 1/9
- Quick Ratio 0.67
- Negative ROE -56.64%
Dividend
0/100
Ref Dividend Yield N/A
Positives
No standout positives identified.
Watchpoints
- No dividend paid
- No capacity for dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$0.48
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ZTEK and closest competitors.
Updated 2026-04-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ZTEK
Zentek Ltd.
Primary
|
-73.0% | -68.8% | -58.3% | -40.7% | -18.6% | -4.0% |
|
POCI
Precision Optics Corporation, Inc.
Peer
|
-7.8% | -29.0% | +17.5% | +13.0% | +13.2% | +17.8% |
|
MGX
Metagenomi Therapeutics, Inc.
Peer
|
-86.4% | -86.4% | -7.9% | -50.9% | -4.1% | +2.9% |
|
PRPO
Precipio, Inc.
Peer
|
-22.7% | +116.7% | +381.3% | +64.1% | -0.9% | +3.9% |
|
PETS
PetMed Express, Inc.
Peer
|
-91.2% | -84.4% | -23.0% | -7.9% | -8.2% | +1.3% |
ZTE
Zentek Ltd.
Primary
5Y
-73.0%
3Y
-68.8%
1Y
-58.3%
6M
-40.7%
1M
-18.6%
1W
-4.0%
POC
Precision Optics Corporation, Inc.
Peer
5Y
-7.8%
3Y
-29.0%
1Y
+17.5%
6M
+13.0%
1M
+13.2%
1W
+17.8%
MGX
Metagenomi Therapeutics, Inc.
Peer
5Y
-86.4%
3Y
-86.4%
1Y
-7.9%
6M
-50.9%
1M
-4.1%
1W
+2.9%
PRP
Precipio, Inc.
Peer
5Y
-22.7%
3Y
+116.7%
1Y
+381.3%
6M
+64.1%
1M
-0.9%
1W
+3.9%
PET
PetMed Express, Inc.
Peer
5Y
-91.2%
3Y
-84.4%
1Y
-23.0%
6M
-7.9%
1M
-8.2%
1W
+1.3%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
5.72
P/S Ratio
54.78
EV/Revenue
54.89
EV/EBITDA
-6.18
Market Cap
$51.65M
Profitability
Profit margins and return metrics
Profit Margin
N/A
Operating Margin
-4155.24%
Gross Margin
50.48%
ROE
-56.64%
ROA
-30.05%
Growth
Revenue and earnings growth rates
Revenue Growth
+73.1%
Earnings Growth
N/A
Q/Q Revenue Growth
+73.07%
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.15
Low debt
Current Ratio
1.0
Weak
Quick Ratio
0.67
Poor
Cash/Share
$0.02
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$0.0B
Gross Margin
-38.2%
Op. Margin
-3655.3%
Net Margin
-3811.5%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.41x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
108%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-06-25
$N/A
2023-02-10
$-0.03
2022-11-14
$-0.04
-33.3% surprise
2022-08-05
$-0.05
-25.0% surprise
Healthcare Sector Comparison
Comparing ZTEK against 548 companies in the Healthcare sector
(30 bullish, 163 neutral, 355 bearish)
Return on Equity (ROE)
-56.64%
This Stock
vs
-89.9%
Sector Avg
-37.0%
(Below Avg)
Debt to Equity
0.15
This Stock
vs
2.71
Sector Avg
-94.3%
(Less Debt)
Revenue Growth
73.1%
This Stock
vs
126.74%
Sector Avg
-42.3%
(Slower)
Current Ratio
1.0
This Stock
vs
4.53
Sector Avg
-78.0%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ZTEK
Zentek Ltd.
|
BEARISH | $51.65M | - | -56.6% | -% | $0.48 | |
|
POCI
Precision Optics Corporation, Inc.
|
BEARISH | $51.36M | - | -73.6% | -28.3% | $4.7 | Compare |
|
MGX
Metagenomi Therapeutics, Inc.
|
BEARISH | $52.67M | - | -44.7% | -% | $1.4 | Compare |
|
PRPO
Precipio, Inc.
|
BEARISH | $50.48M | - | -2.7% | -1.5% | $28.3 | Compare |
|
PETS
PetMed Express, Inc.
|
BEARISH | $50.08M | - | -100.6% | -34.7% | $2.34 | Compare |
ZTEK
Zentek Ltd.
BEARISH
Mkt Cap
$52M
P/E
-
ROE
-56.6%
Price
$0.48
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-09 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.57 per | 6,250 | $3,575 |
| 2026-03-26 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.56 per | 10,000 | $5,630 |
| 2026-02-09 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.73 per | 10,000 | $7,280 |
| 2026-02-06 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.66 per | 11,000 | $7,315 |
| 2026-02-04 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.62 per | 9,000 | $5,598 |
| 2026-02-04 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.64 per | 4,500 | $2,898 |
| 2026-02-04 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.65 per | 1,500 | $976 |
| 2026-01-20 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.85 per | 2,000 | $1,700 |
| 2026-01-19 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.88 per | 1,000 | $880 |
| 2026-01-15 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.94 per | 500 | $468 |
| 2026-01-14 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.96 per | 100 | $96 |
| 2026-01-12 | Van der Kuur (Colin Stuart) | Senior Officer of Issuer | Disposition in the public market at price 1.05 per | 5,000 | $5,260 |
| 2026-01-09 | Van der Kuur (Colin Stuart) | Senior Officer of Issuer | Disposition in the public market at price 0.85 per | 5,000 | $4,240 |
| 2026-01-06 | Jiwan (Mohammed) | Director of Issuer | Acquisition in the public market at price 0.76 per | 7,750 | $5,890 |
| 2026-01-06 | Van der Kuur (Colin Stuart) | Senior Officer of Issuer | Disposition in the public market at price 0.75 per | 10,000 | $7,530 |
Jiwan (Mohammed)
Director of Issuer
2026-04-09
6,250 shares
·
$3,575
Jiwan (Mohammed)
Director of Issuer
2026-03-26
10,000 shares
·
$5,630
Jiwan (Mohammed)
Director of Issuer
2026-02-09
10,000 shares
·
$7,280
Jiwan (Mohammed)
Director of Issuer
2026-02-06
11,000 shares
·
$7,315
Jiwan (Mohammed)
Director of Issuer
2026-02-04
9,000 shares
·
$5,598
Jiwan (Mohammed)
Director of Issuer
2026-02-04
4,500 shares
·
$2,898
Jiwan (Mohammed)
Director of Issuer
2026-02-04
1,500 shares
·
$976
Jiwan (Mohammed)
Director of Issuer
2026-01-20
2,000 shares
·
$1,700
Jiwan (Mohammed)
Director of Issuer
2026-01-19
1,000 shares
·
$880
Jiwan (Mohammed)
Director of Issuer
2026-01-15
500 shares
·
$468
Jiwan (Mohammed)
Director of Issuer
2026-01-14
100 shares
·
$96
Van der Kuur (Colin Stuart)
Senior Officer of Issuer
2026-01-12
5,000 shares
·
$5,260
Van der Kuur (Colin Stuart)
Senior Officer of Issuer
2026-01-09
5,000 shares
·
$4,240
Jiwan (Mohammed)
Director of Issuer
2026-01-06
7,750 shares
·
$5,890
Van der Kuur (Colin Stuart)
Senior Officer of Issuer
2026-01-06
10,000 shares
·
$7,530
Insider transactions can signal confidence or concerns about company prospects
Past News Coverage
Recent headlines mentioning ZTEK from our newsroom.
Newest → oldest
No matching news yet.